首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
HCV PROTEASE INHIBITORS
摘要
<p>This invention relates to the peptide-like compounds of formula (I) as shown herein. These compounds can be used to treat hepatitis C virus infection.</p>
申请公布号
WO2008057995(A2)
申请公布日期
2008.05.15
申请号
WO2007US83440
申请日期
2007.11.02
申请人
LIU, CHEN-FU;KING, CHI-HSIN RICHARD;TAIGEN BIOTECHNOLOGY CO., LTD.;LIN, CHU-CHUNG;CHENG, PEI-CHIN;LIU, YO-CHIN
发明人
LIN, CHU-CHUNG;CHENG, PEI-CHIN;LIU, YO-CHIN;LIU, CHEN-FU;KING, CHI-HSIN RICHARD
分类号
A61K31/4015;A61K31/427;A61K31/497;C07D241/12;C07D417/14;C07D487/04
主分类号
A61K31/4015
代理机构
代理人
主权项
地址
您可能感兴趣的专利
Aparato de autenticación para documentos de valor móviles
Factor de transferencia a partir de huevos de ave
Dispositivo de cierre
Aparato y método para el tratamiento de piezas estructurales
Jet engine comprising a fluidic injection system for shock and mixing noise mitigation
Method Of Manufacturing A Thermoset Polymer Utility Vault Lid
TRAFFIC SIGNAL CONTROL DEVICE, TRAFFIC SIGNAL CONTROL METHOD, AND COMPUTER PROGRAM
METHODS OF FORMING A MEMORY CELL MATERIAL, AND RELATED METHODS OF FORMING A SEMICONDUCTOR DEVICE STRUCTURE, MEMORY CELL MATERIALS, AND SEMICONDUCTOR DEVICE STRUCTURES
AN AEROSOL-GENERATING SYSTEM COMPRISING A FLUID PERMEABLE SUSCEPTOR ELEMENT
BUPRENORPHINE DIMER AND ITS USE IN TREATMENT OF GASTROINTESTINAL DISORDERS
PHARMACEUTICALLY ACTIVE DIMERS LINKED THROUGH PHENOLIC HYDROXYL GROUPS
DRUG FOR TREATMENT OF TINNITUS PATIENTS
BICYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME
GLAZED SOLAR COLLECTORS
HYDROGENATED POLYMERS WITH A RADIAL STRUCTURE HAVING A CORE BASED ON CALIXARENES AND USE THEREOF IN LUBRICANT COMPOSITIONS
SMART THERMAL PATCH FOR ADAPTIVE THERMOTHERAPY
VEHICLE ONBOARD COMMUNICATION TERMINAL AND MOBILE COMMUNICATION SYSTEM
SINGLE-SERVE CAPSULE AND METHOD FOR PREPARING A BEVERAGE USING A SINGLE-SERVE CAPSULE
ENRICHMENT AND CHARACTERIZATION OF HUMAN CORNEAL ENDOTHELIAL CELLS (HCENC) WITH NOVEL MONOCLONAL ANTIBODY
METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY